Compared to astrocytomas, GBM demonstrated a significantly decreased proportion of CDKN2A+ tumor cells, indicating an increased proportion of proliferating cells in GBM [27]. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).